Corporate Development, Finance and Administration.Proception Medical in-licenses technologies from surgeon/inventors, improves the technology, develops products based on the technology, gains FDA clearance, executes a limited launch and then license the product to medical device companies.

Chief Financial Officer July 2012 – May 2013Interim Chief Executive Officer October 2012 – January 2013A privately held medical device company that launched its first two commercial products in 2012 and was on track to achieve $6 million in sales in 2013. Named interim CEO 3 months after being hired as CFO. As CFO was responsible for all financial functions, all administrative functions and supply chain management. As Interim CEO was responsible for all aspects of the company’s… Show more Chief Financial Officer July 2012 – May 2013Interim Chief Executive Officer October 2012 – January 2013A privately held medical device company that launched its first two commercial products in 2012 and was on track to achieve $6 million in sales in 2013. Named interim CEO 3 months after being hired as CFO. As CFO was responsible for all financial functions, all administrative functions and supply chain management. As Interim CEO was responsible for all aspects of the company’s operations.• Developed and led a change in business model from a fixed cost model to a variable cost model. This initiative substantially reduced the company’s burn while the sales growth trajectory was maintained through the provision of results based incentives for the sales force.• Led simultaneous negotiations with world class VC firm and institutional investor for the provision of sufficient capital to see the company through to cash flow positive. This ultimately resulted in the successful completion of a $10M financing.• Secured asset based financing for the company that was critical for the company’s survival while negotiating for institutional financing. Show less

Chief Financial Officer May 2006 – March 2010Chief Operating and Financial Officer, Member of the Board of Directors March 2010 – December 2011Consultant January 2012 – March 2012A publicly traded, development stage, specialty pharmaceutical company that was acquired in December 2011.• Responsible for all financial and administrative functions and shared responsibility with CEO for the overall business strategy, business development and product development.• Led the… Show more Chief Financial Officer May 2006 – March 2010Chief Operating and Financial Officer, Member of the Board of Directors March 2010 – December 2011Consultant January 2012 – March 2012A publicly traded, development stage, specialty pharmaceutical company that was acquired in December 2011.• Responsible for all financial and administrative functions and shared responsibility with CEO for the overall business strategy, business development and product development.• Led the transformation from a true biotech with high risk, high reward, high costs products and a large staff to a virtual specialty pharma company focusing on low risk, low cost, quick to market products through a small staff augmented by a group of expert consultants.• Led 2 successful merger transactions.• Led the sale of the company. • Led four PIPE transactions which provided over $40 million in operating capital for the Company. Show less

Chief Financial Officer 2001 - 2006A publicly traded, drug delivery company that manufactured and launched its first FDA-approved, drug/device combination product in 2005.• Responsible for all financial and administrative functions and shared responsibility with CEO for the overall business strategy, business development and product development.• Managed significant growth from a 20 employee research and development operation to an 80 employee, FDA-approved manufacturing and… Show more Chief Financial Officer 2001 - 2006A publicly traded, drug delivery company that manufactured and launched its first FDA-approved, drug/device combination product in 2005.• Responsible for all financial and administrative functions and shared responsibility with CEO for the overall business strategy, business development and product development.• Managed significant growth from a 20 employee research and development operation to an 80 employee, FDA-approved manufacturing and commercial enterprise.• Guided the company through a reverse merger and simultaneous $25M financing. Fully prepared the company to be a publicly-traded entity in 6 months.• Led several other financing transactions securing over $50 million in operating capital. Show less